Increased functional response to cocaine challenge following recovery from chronic corticosterone in the rat

European Journal of Pharmacology

Volumn 336, Issue 2-3, 1997, Pages 159-162

  Patacchioli, Francesca R ^a   Pontieri, Francesco E ^b   Di Grezia, Renato ^c   Colangelo, Vittorio ^c   Angelucci, Luciano ^a   Orzi, Francesco ^c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c IRCCS NEUROMED   (Italy)

Author keywords

Cocaine; Corticosterone; Deoxyglucose; Rat

Indexed keywords

COCAINE; CORTICOSTERONE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN; BRAIN REGION; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; GLUCOSE UTILIZATION; MALE; METABOLISM; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIZATION; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BRAIN; COCAINE; CORTICOSTERONE; DEOXYGLUCOSE; DOPAMINE UPTAKE INHIBITORS; GLUCOSE; MALE; RATS; RATS, WISTAR;

EID: 0030708547     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01274-0     Document Type: Article

References (16)

1. 14C ]-deoxyglucose method for use in freely moving rats Brain Res. 499:1989;87-92.
2. Hall E.D. Glucocorticoid effects on the central nervous excitability and synaptic transmission. Int. J. Neurobiol. 23:1982;165-169.
3. Leret M.L., Tranque P., Gonzales I., Calvo J.C. Possible interaction of the adrenal-gonadal systems on brain catecholamines of adult rats. Comp. Biochem. Physiol. 86C:1987;295-298.
4. Ling M.H.M., Perry P.J., Tsuang M.T. Side-effects of corticosteroid therapy. Arch. Gen. Psychiatry. 38:1981;471-479.
5. Marinelli M., Piazza P.V., Deroche V., Maccari S., LeMoal M., Simon H. Corticosterone circadian secretion differentially facilitates dopamine-mediated psychomotor effects of cocaine and morphine. J. Neurosci. 14:1994;2724-2731.
6. Orzi F., Passarelli F., La Riccia M., Di Grezia R., Pontieri F.E. Intravenous morphine increases glucose utilization in the shell of the rat nucleus accumbens. Eur. J. Pharmacol. 302:1996;49-51.
7. Patacchioli, F.R., Pontieri, F.E., Orzi, F., Di Grezia, R., Angelucci L. Increased locomotor response to acute cocaine administration following recovery from chronic corticosterone treatment in the rat. Eur. Neuropsychopharmacol., in press.
8. Piazza P.V., Marinelli M., Jodogne C., Deroche V., Rougé-Pont F., Maccari S., LeMoal M., Simon H. Inhibition of corticosterone synthesis by metyrapone decreases cocaine-induced locomotion and relapse of cocaine self-administration. Brain Res. 658:1994;259-264.
9. Pontieri F.E., Colangelo V., La Riccia M., Pozzilli C., Passarelli F., Orzi F. Psychostimulant drugs increase glucose utilization in the shell of the rat nucleus accumbens. NeuroReport. 5:1994;2561-2564.
10. Pontieri F.E., Tanda G., Di Chiara G. Intravenous cocaine, morphine and amphetamine preferentially increase extracellular dopamine in the 'shell' as compared to the 'core' of the rat nucleus accumbens. Proc. Natl. Acad. Sci. USA. 92:1995;12304-12308.
11. Pontieri F.E., Tanda G., Orzi F., Di Chiara G. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature. 382:1996;255-257.
12. Porrino L.J. Functional correlates of acute cocaine treatment depend on route of administration. Psychopharmacology. 112:1993;343-351.
13. Rastogi R.B., Singhal R.L. Evidence for the role of adrenocortical hormones in the regulation of noradrenaline and dopamine metabolism in certain brain areas. Br. J. Pharmacol. 62:1978;131-136.
14. Sapolsky R.M., Krey L.C., McEwen B.S. Prolonged glucocorticoid exposure reduces hippocampal neuron number: Implications for aging. J. Neurosci. 5:1985;1222-1227.
15. 14C ]deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure and normal values in the conscious and anesthetized albino rat J. Neurochem. 28:1977;897-916.
16. Wolkowitz O., Sutton M., Koulu M., Labarca R., Wilkinson L., Doran A., Hauger R., Pickar D., Crawley J. Chronic corticosterone administration in rats: Behavioural and biochemical evidence of increased central dopaminergic activity. Eur. J. Pharmacol. 122:1986;329-338.